A detailed history of Jpmorgan Chase & CO transactions in Silk Road Medical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 34,869 shares of SILK stock, worth $958,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,869
Previous 34,270 1.75%
Holding current value
$958,548
Previous $627,000 50.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$16.95 - $27.04 $10,153 - $16,196
599 Added 1.75%
34,869 $942,000
Q1 2024

May 10, 2024

SELL
$11.38 - $19.03 $846,307 - $1.42 Million
-74,368 Reduced 68.45%
34,270 $627,000
Q4 2023

Feb 12, 2024

BUY
$6.29 - $15.72 $240,491 - $601,038
38,234 Added 54.31%
108,638 $1.33 Million
Q3 2023

Nov 14, 2023

SELL
$14.99 - $32.65 $566,741 - $1.23 Million
-37,808 Reduced 34.94%
70,404 $1.06 Million
Q2 2023

Aug 11, 2023

SELL
$29.76 - $46.14 $2.89 Million - $4.49 Million
-97,248 Reduced 47.33%
108,212 $3.52 Million
Q1 2023

May 18, 2023

BUY
$38.09 - $57.79 $1.81 Million - $2.74 Million
47,416 Added 30.0%
205,460 $8.04 Million
Q1 2023

May 11, 2023

BUY
$38.09 - $57.79 $2.1 Million - $3.19 Million
55,245 Added 53.74%
158,044 $6.18 Million
Q4 2022

Feb 13, 2023

SELL
$40.54 - $56.2 $498,642 - $691,260
-12,300 Reduced 10.69%
102,799 $5.43 Million
Q3 2022

Nov 14, 2022

SELL
$36.98 - $49.2 $126,138 - $167,821
-3,411 Reduced 2.88%
115,099 $5.18 Million
Q2 2022

Aug 11, 2022

BUY
$28.03 - $45.8 $1.37 Million - $2.24 Million
48,951 Added 70.37%
118,510 $4.31 Million
Q1 2022

May 11, 2022

SELL
$29.24 - $44.06 $9,853 - $14,848
-337 Reduced 0.48%
69,559 $2.87 Million
Q4 2021

Feb 10, 2022

SELL
$39.32 - $61.61 $470,188 - $736,732
-11,958 Reduced 14.61%
69,896 $2.98 Million
Q3 2021

Nov 12, 2021

BUY
$44.0 - $65.8 $3.6 Million - $5.39 Million
81,854 New
81,854 $4.51 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.